Journal of Assisted Reproduction and Genetics

, Volume 13, Issue 8, pp 629–634 | Cite as

Relative bioactivity of endogenous luteinizing hormone during superovulation therapy for in vitro fertilization in normal-cycling women

  • M. I. Abuzeid
  • J. K. Hodges
  • C. R. Harlow
  • M. G. R. Hull
Clinical Assisted Reproduction


Purpose: Impaired outcome of in vitro fertilization treatment has been related to abnormal luteining hormone (LH) secretion and to the occurrence of a premature LH surge. The purpose of this study was to compare LH serum concentrations, measured by bioassay (LH-b) and immunoassay (LH-i), during early and late follicular phases in normal-ovulatory women who were stimulated with clomiphene, human menopausal gonadotropin (HMG), and human chorionic gonadotropin (hCG), while undergoing in vitro fertilization (IVF) treatment for infertility, due mainly to tubal damage.

Results: Of 22 patients, 15 had an LH surge (surge group) before receiving hCG and 7 did not (nonsurge group). LH-b and LH-i concentrations were higher in the late follicular phase than before clomiphene treatment, but the LH-b/LH-i (B/I) ratios remained unchanged and there were no significant differences between the LH surge and the nonsurge groups. In the surge group, the B/I ratio appeared to fall during the LH surge [presurge values, 5.4 ± 0.5 (SD) and 5.2 ± 0.5; surge values, 4.9 ± 0.6 and later 4.0 ± 0.6], but the differences were not significant, and in some individuals, the B/I ratio later rose as the LH surge progressed.

Conclusions: Our findings suggest that interference with IVF outcome by a spontaneous LH surge is due to quantitative and/or exposure time effects on the oocyte, rather than to any qualitative variation in bioactivity of LH.

Key words

luteinizing hormone bioactivity superovulation in vitro fertilization 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Marut EL, Williams RF, Cowan DD, Lunch A, Lerner SP, Hodgen GD: Pulsatile pituitary gonadotropin secretion during maturation of the dominant follicle in monkeys: estrogen positive feedback enhances the biological activity of LH. Endocrinology 1981;109:2270–2272PubMedGoogle Scholar
  2. 2.
    Velduis JD, Beitins IZ, Johnson ML, Serabian MA, Dufau ML: Biologically active lutenizing hormone is secreted in episodic pulsations that vary in relation to stage of menstrual cycle. J Clin Endocrinol Metab 1984;58:1050–1058PubMedGoogle Scholar
  3. 3.
    Abuzeid MI, Yeoman R, Aksel S: Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles. Fertil Steril 1987;47:238–243PubMedGoogle Scholar
  4. 4.
    Shoham Z, Jacobs HS, Insler V: Luteinizing hormone: Its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 1993;59:1153–1161PubMedGoogle Scholar
  5. 5.
    Talbert LM: Endogenous luteinizing hormone surge and superovulation. Fertil Steril 1987;49:24–25Google Scholar
  6. 6.
    Messinis IE, Templeton A, Baird DT: Relationship between the characteristics of endogenous luteinizing hormone surge and the degree of ovarian hyperstimulation during the superovulation induction in women. CVI in Endocrinol 1986;25:393–400Google Scholar
  7. 7.
    VanDamme MP, Robertson DM, Diczfalusy E: An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta Endocrinol 1974;77:655–671PubMedGoogle Scholar
  8. 8.
    Webb R, Baxter G, McBridge D, Nordblom GD, Shaw MKP: The measurement of testosterone and estradiol-17B using iodinated tracers and incorporating an affinity chromatography extraction procedure. J Steroid Biochem 1985;23:1043–1050PubMedGoogle Scholar
  9. 9.
    Pepperell RJ, de Kretser DM, Burger HG: Studies on the metabolic clcarance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man. J Clin Invest 1975;56:118–126PubMedGoogle Scholar
  10. 10.
    Howles CM, Macnamee MC, Edwards RG, Goswamy R, Steptoe PC: Effect of high tonic levels of luteinizing hormone on outcome of in vitro fertilization. Lancet 1986;2:521.PubMedGoogle Scholar
  11. 11.
    Stanger JD, Yovich JL: Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynecol 1985;92:385–393Google Scholar
  12. 12.
    Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van deKoppel P, Collins JA: The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888–896PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • M. I. Abuzeid
    • 1
  • J. K. Hodges
    • 2
  • C. R. Harlow
    • 1
  • M. G. R. Hull
    • 1
  1. 1.Department of Obstetrics and Gynecology, St. Michael's HospitalUniversity of BristolBristolU.K.
  2. 2.Department of Reproductive BiologyGerman Primate CenterGettingenGermany

Personalised recommendations